APA引文

Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., . . . Chattipakorn, S. C. (2020). Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats.

Chicago Style Citation

Arunsak, Busarin, et al. Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor Exerts Greater Efficacy Than Atorvastatin On Improvement of Brain Function and Cognition in Obese Rats. 2020.

MLA引文

Arunsak, Busarin, et al. Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor Exerts Greater Efficacy Than Atorvastatin On Improvement of Brain Function and Cognition in Obese Rats. 2020.